XML 45 R3.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED INCOME STATEMENT - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Profit or loss [abstract]      
Net revenues € 153,508 € 156,878 € 189,544
Cost of revenues 155,627 136,360 151,400
Selling, general and other costs 8,967 9,299 9,541
Research and development costs 11,145 5,784 5,619
Gains/(losses) on disposal of investments (1,839) (98) 20
Restructuring costs 913 1,617 1,119
Share of the profit/(loss) of equity method investees (1,271) (33) 491
Total (26,254) 3,687 22,376
Net financial expenses/(income) 351 (345) (42)
Profit/(loss) before taxes (26,605) 4,032 [1] 22,418 [1]
Tax expense/(benefit) (4,273) (1,488) 3,793
Net profit/(loss) (22,332) 5,520 18,625
Net profit/(loss) attributable to:      
Owners of the parent (22,368) 5,473 18,596
Non-controlling interests € 36 € 47 € 29
Earnings/(loss) per share:      
Basic earnings per share (in EUR per share) € (7.75) € 1.86 € 5.98
Diluted earnings per share (in EUR per share) € (7.75) € 1.84 € 5.94
[1] (1) Certain line items in prior periods have been reclassified to enhance the consistency and comparability of the financial disclosures.
Refer to Note 1, Basis of presentation for additional information